Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE projectLorenz Balcar, Michael Schwarz, Livia Dorn, et al.
Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE projectLorenz Balcar, Michael Schwarz, Livia Dorn, et al.
Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 12